SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-015633
Filing Date
2024-04-10
Accepted
2024-04-10 16:43:31
Documents
19
Period of Report
2024-04-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A cort-20240410.htm   iXBRL DEF 14A 1150165
6 cort-20240410_g1.jpg GRAPHIC 137758
7 cort-20240410_g2.jpg GRAPHIC 106252
8 cort-20240410_g3.jpg GRAPHIC 105394
9 cort-20240410_g4.jpg GRAPHIC 183288
10 cort-20240410_g5.jpg GRAPHIC 205492
  Complete submission text file 0001628280-24-015633.txt   3771881

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20240410.xsd EX-101.SCH 3580
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20240410_def.xml EX-101.DEF 4764
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20240410_lab.xml EX-101.LAB 6371
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20240410_pre.xml EX-101.PRE 3750
22 EXTRACTED XBRL INSTANCE DOCUMENT cort-20240410_htm.xml XML 167313
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50679 | Film No.: 24836339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)